Featured « AGORACOM Small-cap Investor Relations Blog

Archive for the ‘Featured’ Category

KABN NA $KABN.ca Receives Subscription Agreements for C$2,970,000 Investment at $0.33 CDN per Unit $MOS.ca $MOGO.ca $CTZ.ca $PTO.ca $PAY.ca

Posted by AGORACOM-JC at 11:31 AM on Tuesday, August 18th, 2020

Announced that it has received and accepted irrevocable subscriptions from a group of arm’s-length U.S. family office and foreign investors, for a total of 9 million common share units for gross proceeds of C$2,970,000
Each Unit is priced at C$0.33 per Unit.
Each Unit consists of one common share of the Company and ½ Common Share purchase warrant, with each whole Warrant entitling the holder to purchase one Common Share for C$0.37 per share for 24 months from closing of the transaction
“This agreement largely stems from the increasing recognition of Liquid Avatar as a potential game changer in the world of digital identity verification, management and monetization. We look forward to closing this financing over the next couple of weeks and continue to execute and deliver on our business programs,” said Ben Kessler, CEO – KABN North America

Toronto, Canada, August 18, 2020 – KABN Systems NA Holdings Corp. (CSE:KABN) (the “Company” or “KABN” or “KABN North America”), a Canadian Fintech company that specializes in continuous online identity verification, management and monetization in Canada and the U.S., is pleased to announce that it has received and accepted irrevocable subscriptions from a group of arm’s-length U.S. family office and foreign investors, for a total of 9 million common share units (“Units”) for gross proceeds of C$2,970,000.

Each Unit is priced at C$0.33 per Unit. Each Unit consists of one common share of the Company (“Common Shares”) and ½ Common Share purchase warrant (“Warrants”), with each whole Warrant entitling the holder to purchase one Common Share for C$0.37 per share for 24 months from closing of the transaction. No fees were paid in association with the financing. In accordance with applicable securities rules and regulations, the Common Shares and the Warrants comprised in the Units, and the Common Shares issuable on exercise of the Warrants, will be subject to hold periods ranging from 4 months to 1 year, with the majority of the offering subject to a 1 year hold, restricting shares and warrants from transfer or trading except as permitted by law.

“This agreement largely stems from the increasing recognition of Liquid Avatar as a potential game changer in the world of digital identity verification, management and monetization. We look forward to closing this financing over the next couple of weeks and continue to execute and deliver on our business programs,” said Ben Kessler, CEO – KABN North America

The expected date of closing is on or before August 31, 2020, and may be extended by the Company. The proceeds of the financing will provide working capital to further accelerate the Company’s development, customer acquisition and business platform consisting of Liquid Avatar, KABN ID, KABN KASH and KABN’s Visa Card program.

The KABN North American Fintech suite of products and services is comprised of:

Liquid Avatar allows users to create high quality digital icons representing their online personas. These icons, in conjunction with KABN ID, allows users to manage and control their Digital Identity and to use Liquid Avatars to share public and permission based private data when they want and with whom they want. www.liquidavatar.com

KABN ID is an Always On, biometric and blockchain based digital identity validation and verification platform allowing users to continuously and confidently prove themselves throughout the online community.

KABN Card is a Visa approved prepaid card program allowing users to manage both digital and fiat currencies and earn cashback and other loyalty incentives. www.kabncard.com

KABN KASH is a cashback, loyalty and engagement program that powers the KABN revenue ecosystem.

KABN provides its products and services at no cost to consumers and generates revenues through permission-based partner programs. www.kabnkash.com

The Company welcomes the public to request an invitation to be an early adopter of Liquid Avatar and earn rewards at: https://liquidavatar.com/liquid-avatar-early-adopter/

About KABN North America – www.kabnnaholdco.com

KABN Systems NA Holdings Corp. through its wholly owned subsidiary KABN Systems North America Inc. focuses on the verification, management and monetization of digital identity, empowering users to control and benefit from its use of their online identity. KABN propriety technology suite includes 4 key products:

KABN Card is a Visa approved prepaid card program allowing users to manage both digital and fiat currencies and earn cashback and other loyalty incentives. www.kabncard.com

KABN KASH is a cashback, loyalty and engagement program that powers the KABN revenue ecosystem.

KABN provides its products and services at no cost to consumers and generates revenues through permission-based partner programs. www.kabnkash.com

For more information, please visit www.kabnnaholdco.com or www.kabnsystemsna.com

For further information, please contact:

Ben Kessler

Chief Executive Officer

647-725-7742 Ext. 700

[email protected]

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

This news release does not constitute an offer to sell, or a solicitation of an offer to buy, any securities under the KABN Financing in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

Forward-Looking Information and Statements

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. The forward-looking information and forward-looking statements contained herein may include, but is not limited to, information concerning the ability of the Company to generate revenues, roll out new programs and to successfully achieve business objectives, including to accelerate the Company’s development, customer acquisition and business platform, and expectations for other economic, business, and/or competitive factors.

By identifying such information and statements in this manner, the Company is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such information and statements. In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, the Company has made certain assumptions. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information and statements are the following: changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws; compliance with extensive government regulation. Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.

Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws.

Tags: blockchain, canadian fintech, crypto, CSE, Liquid Avatars, tsx
Posted in Featured, KABN, KABN Systems NA Holdings Corp. | Comments Off on KABN NA $KABN.ca Receives Subscription Agreements for C$2,970,000 Investment at $0.33 CDN per Unit $MOS.ca $MOGO.ca $CTZ.ca $PTO.ca $PAY.ca

Thoughtful Brands $TBI.ca Enters into Letters of Intent to Consider Acquisitions of Golden Path and Wild Mariposa $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $SHRM.ca $RVV.ca

Posted by AGORACOM-JC at 6:02 PM on Monday, August 17th, 2020

Entered into letters of intent with Golden Path LLC and Wild Mariposa LLC, pursuant to which it proposes to acquire all of the outstanding membership interests in both companies
Golden Path and Wild Mariposa are arms-length privately held companies involved in the online marketing and distribution of consumer health products

VANCOUVER, BC / August 17, 2020 / Thoughtful Brands Inc. (CSE:TBI)(FWB:1WZ1:GR)(OTCQB:PEMTF) (the “Company“) is pleased to announce that it has entered into letters of intent (collectively, the “Letters of Intent“), each dated August 17, 2020, with Golden Path LLC (“Golden Path“) and Wild Mariposa LLC (“Wild Mariposa“), pursuant to which it proposes to acquire all of the outstanding membership interests in both companies. Golden Path and Wild Mariposa are arms-length privately held companies involved in the online marketing and distribution of consumer health products.

Golden Path and Wild Mariposa are direct-to-consumer eCommerce brands selling a range of natural health products, including nutraceutical and hemp-based CBD products within the United States. Each product is carefully crafted based on market demand and product quality. Every product manufactured is third-party tested for purity and manufactured in the United States in GMP certified facilities. Both brands are current clients of Unified Funding, LLC which is contracted to perform a number of eCommerce business operations.

“We are excited to look at the acquisition of these two established natural health brands as a further step in our eCommerce expansion in North America. Both brands possess product lines that are complimentary to Nature’s Exclusive and bring a large existing customer base along with nutraceutical product formulations and manufacturing relationships. Our timing is very strategic to acquire these brands as we near the closing of the Unified Funding asset acquisition, which will manage all go forward eCommerce operations for Thoughtful Brands”, stated Ryan Hoggan, CEO of the Company.

The Letters of Intent contemplate that the Company would acquire Golden Path, and Wild Mariposa, in consideration for the issuance of 11,544,400 common shares and 15,055,600 common shares (collectively, the “Consideration Shares“), respectively. The Consideration Shares will be issued to the existing members of Golden Path, and Wild Mariposa, at a deemed price of Cdn$0.195 per share.

The Company is at arms-length from each of Golden Path, Wild Mariposa and their respective members. The transactions contemplated by the Letters of Intent do not constitute a fundamental change for the company, nor are they expected to result in a change of control of the Company, within the meaning of applicable securities laws and the policies of the Canadian Securities Exchange. The transactions are contingent upon each other, and the Company does not intend to proceed with the transactions unless both can be completed concurrently. Upon completion of the transactions, an administrative fee of 266,000 common shares of the Company will be owing to a consultant who assisted with the transactions.

The transactions remain subject to a number of conditions, including completion of due diligence, receipt of any required regulatory approval and the negotiation of definitive documentation, which is expected to include warranties, representations, covenants, terms and conditions which are customary and consistent with industry standards for transactions of this nature. The transactions cannot be completed until these conditions have been satisfied.

About Thoughtful Brands Inc.

Thoughtful Brands Inc. is an eCommerce technology company that researches, develops, markets, and distributes natural health products through various brands in North America and Europe. Through continuous strategic acquisitions, the Company has a strong footprint in the CBD market, as well as the burgeoning psychedelic medicine sector. Thoughtful Brands owns and operates a 110,000 square foot pharmaceutical manufacturing facility in Radebeul, Germany, where its highly skilled team conducts clinical studies utilizing naturally occurring psilocybin and other compounds found in psychedelics for the treatment of opiate addiction, while planning for future opportunities to create proprietary psilocybin products.

ON BEHALF OF THE BOARD OF DIRECTORS

THOUGHTFUL BRANDS INC.
Ryan Hoggan
Chief Executive Officer

For further information, readers are encouraged to contact Joel Shacker, President at +604.423.4733 or by email at [email protected] or www.motaventuresco.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this press release, which has been prepared by management.

Cautionary Note Regarding Forward-Looking Statement

All statements in this press release, other than statements of historical fact, are “forward-looking information” with respect to the Company within the meaning of applicable securities laws, including with respect to its plans to acquire Golden Path and Wild Mariposa, along with additional revenue-producing natural health product brands and operations in both Europe and North America with the goal of establishing an international distribution network utilizing its eCommerce technology platform. The Company provides forward-looking statements for the purpose of conveying information about current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. These risks and uncertainties include but are not limited those identified and reported in the Company’s public filings under the Company’s SEDAR profile at www.sedar.com. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise unless required by law.

SOURCE: Thoughtful Brands Inc.

Tags: #Europe, #Psilocybin, #psychedelic, #Sales, Cannabis, CBD, CSE, Golden Path, Wild Mariposa
Posted in Featured, Thoughtful Brands Inc. | Comments Off on Thoughtful Brands $TBI.ca Enters into Letters of Intent to Consider Acquisitions of Golden Path and Wild Mariposa $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $SHRM.ca $RVV.ca

Avicanna $AVCN.ca Reports Second Quarter 2020 Financial Results and Provides Corporate Update $WEED.ca $CL.ca $HEXO.ca $RWB.ca

Posted by AGORACOM-JC at 7:36 AM on Monday, August 17th, 2020

http://www.smallcapepicenter.com/Avicana%20square%20logo.jpg

Successfully launched advanced “medical cannabis 2.0” products under RHO Phyto™ brand nation-wide in Canada through Medical Cannabis by Shoppers™, a subsidiary of Shoppers Drug Mart
Revenue increase of 172% from $260,903 in Q1 2020 to $709,468 in Q2 2020, and a substantial increase from $16,571 in Q2 2019, coupled with 8% cost reduction from Q1 2020, and 31% cost reduction from Q2 2019
Continued to fortify cannabinoid research and clinical leadership position in Canada with advancements with several collaborations with world class institutions including the MC-RWE by UHN

TORONTO, Aug. 17, 2020 – Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products announces results for the three and six months ended June 30, 2020.

Aras Azadian, Chief Executive Officer of Avicanna, commented “We continued to make strategic, scientific and commercial progress during the quarter while optimizing our global operations, which is demonstrated through quarter to quarter revenue increases and cost reductions. We are at an inflection point where our differentiated and advanced product lines are commencing sales in major markets and we are demonstrating evidence of our diversified business model which is comprised of seeds, API, advanced finished products, and royalties from intellectual property. Furthermore, we continue to fortify our thought leadership position within the medical community in Canada with various world class research collaborations, which now include the strategically significant real-world evidence trials on our RHO Phyto products available in the Canadian market.”

First Quarter Financial and Operational Highlights

The Company continued to make strides in its strategic commercial initiatives, leading to an increase in revenues of 172% from $260,903 in the first quarter of 2020 to $709,468 in the second quarter of 2020, and an increase of 4,181% from $16,571 in the second quarter of 2019. In addition, the Company was able to reduce general and administrative costs by approximately 8% from $3,185,943 in the first quarter of 2020 to $2,924,462 in the second quarter of 2020 and a decrease of 31% from $4,243,276 in the second quarter of 2019. The Company has approximately $3.9M of inventory available for sale.

	Three Month
	Q2 2020	Q1 2020	Q2 2019
Revenue	$709,486	$260,903	$16,571
G&A	$2,924,462	$3,185,943	$4,243,276

The Company announced the co-development of a cannabinoid-based product for treatment of COVID-19 related lung inflammation in partnership with the University of Toronto, with additional support and funding from the Mitacs Accelerate Program grant (the “Mitacs Grant“). Dr. Christine Allen is a global leader in the research and development of pharmaceutical formulations and for the past three years, Avicanna and Dr. Christine Allen’s research group (“CARG“) have developed novel cannabinoid-based products for commercialization. The combined expertise of Avicanna and CARG will fast-track the development of advanced pharmaceutical formulations of cannabinoids and their route to market.
The Company announced the successful registration of the Company’s initial line of products for its CBD-based derma-cosmetic product line, Pura H&W, in the European Union. The Company is anticipating the commercial launch of its Pura H&W line in the United Kingdom in the third quarter of 2020. Avicanna successfully met all regulatory requirements of the European Commission’s Cosmetic Product Notification Portal (the “CPNP“). In addition to the clinical studies conducted on two of the registered products, Avicanna has provided the CPNP with long-term stability studies on these initial SKUs along with primary skin irritation evaluations for the entire portfolio in order to certify the safety and stability of the Pura H&W formulations.
Through its genetics and seed division, Avesta Genetica, Avicanna completed its first industrial-scale seed harvest in Colombia. Approximately 80 million premium and feminized cannabigerol (“CBG“) dominant seeds were successfully harvested. The seeds have been tested for germination and attained feminization rates of 99%, which are considered premium within the global seed market. The seeds will be utilized for sales, exports, and local production. Additionally, the Company’s first ever export of hemp seeds (genetics) was approved by the Colombian government, which was also the first export of cannabis or hemp seeds in Colombian history.
The Company entered a strategic manufacturing and intellectual property (“IP“) licensing agreement with MediPharm Labs Inc. (“MediPharm“). Under the terms of the agreement, MediPharm will use its manufacturing capabilities under its Good Manufacturing Practice (“GMP“) certification in Canada to produce Avicanna’s advanced RHO Phyto medical cannabis products, and Pura H&W topicals for sale by Medical Cannabis by Shoppers. The partnership provides Avicanna with a route to market for Canadian and international sales, as well as pharmaceutical manufacturing for clinical trials with its Canadian research hospital collaborators. Additionally, Avicanna will grant MediPharm a license to use proprietary Avicanna formulations to develop additional white label branded products for the domestic and international market. MediPharm’s pharmaceutical and GMP-certified manufacturing capabilities and its international supply chain capabilities will be leveraged to produce and deliver the proprietary finished products to partners worldwide.
At the height of the COVID-19 pandemic, the Company closed a non-brokered private placement for approximately $2.56 million, issuing 3,200,000 units at a price of $0.80 per unit. The financing primarily included strategic partners, including Tasly International Capital Limited, a division of Tasly Holding Group Co., Ltd., a large healthcare and pharmaceutical group in China.
The Company reduced its operating cash outflows by approximately 40%, for the six months ending June 30, 2020, compared to the six months ending June 30, 2019.

Recent Developments

The Company’s RHO Phyto medical cannabis products launched on the Medical Cannabis by Shoppers portal, commencing with the “Micro Drop” oil formulations. Micro Drop oil formulations are the first of the RHO Phyto formulary of advanced medical cannabis products available for patients and health care practitioners on the Medical Cannabis by Shoppers platform. This product line includes advanced formulations under the “Cannabis 2.0” regulations that have undergone years of research and development and been manufactured under GMP standards by MediPharm. RHO Phyto sublingual sprays and topical products are expected to be available through the Medical Cannabis by Shoppers platform in the third quarter of 2020, with capsules to follow in the fourth quarter. Medical Cannabis by Shoppers is a subsidiary of Shoppers Drug Mart Inc.
On August 11, 2020, the Company announced a strategic partnership with Red White & Bloom Brands Inc. (“RWB”), a multi-state operator active in the U.S. cannabis and hemp sectors, for the distribution of and commercialization of Pura H&W Hemp-Derived CBD-Based Topical Products in the United States. RWB will pay Avicanna an upfront fee in the amount of CAD$250,000 in cash, along with minimum purchase requirements, including the purchase of USD$250,000 worth of product within the first six months of the term, for the rights to be the exclusive distributor of Avicanna’s Pura H&W branded cosmetic products in the US. Under the agreement, RWB also has the right to purchase Avicanna’s cosmetic products for distribution into the US and certain other territories under brands of RWB’s choosing. The initial product offerings under the agreement will include body and face lotions, cosmetic creams, gels and serums, as well as soaps and bath bombs.
Avicanna, in collaboration with CARG at the Leslie Dan Faculty of Pharmacy at the University of Toronto, was awarded additional non-dilutive funding in the form of a peer-reviewed grant by the Natural Sciences and Engineering Research Council of Canada (“NSERC“) to develop a cannabinoid-based formulation for the treatment of COVID-19 related lung inflammation. This peer reviewed grant provides funding support in addition to the recently awarded Mitacs Grant.
In collaboration with Dr. Jibran Khokhar, an Assistant Professor at the University of Guelph, Avicanna was also awarded a two-year NSERC Alliance grant to evaluate the neurobiological underpinnings of cannabis toxicosis in a preclinical model, and to test the potential efficacy of Avicanna’s naturally-derived cannabinoids and formulations for treatment of tetrahydrocannabinol (“THC“) overdose.
In anticipation of the launch of the RHO Phyto product line in Canada, Avicanna hosted its third annual symposium, “Medical Cannabis 2.0”, on July 21^st, 2020 through a virtual format. The presentations focused on the evolution of medical cannabis including the Avicanna led advancements in R&D for novel cannabinoid delivery forms and formulations. Presenters including Dr. Ruth Ross (Professor and Chair, Department of Pharmacology & Toxicology, Faculty of Medicine, University of Toronto, Senior Scientist, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health) and Dr. Hance Clarke (Staff Anesthesiologist, Director Pain Services, Director Good Hope Ehlers Danlos Clinic, Medical Director of The Pain Research Unit, Department of Anesthesia and Pain Management, Toronto General Hospital, University Health Network, Associate Professor, Department of Anesthesia, University of Toronto). Over 1,000 participants attended the symposium.
Avicanna announced that its RHO Phyto line of products will be participating in a Medical Cannabis Real-World Evidence (“MC-RWE“) clinical study at the University Health Network (“UHN“) in partnership with Medical Cannabis by Shoppers. The study will be led by Dr. Hance Clarke, Director of Pain Services at Toronto General Hospital, and will examine the efficacy of a select group of medical cannabis products including Avicanna’s RHO Phyto line of products on patient reported outcomes of pain, sleep and anxiety. All products used in MC-RWE must complete analytical testing through select testing laboratories and entered through the TruTrace StrainSecure™ platform. This provides Avicanna with a second commercial channel to the Medical Cannabis by Shoppers portal for its medical products to UHN, which is Canada’s largest network of research hospitals and doctors.

Summary of Operations ($CDN)

	Three Months Ended	Six Months Ended

	June 30, 2020	June 30, 2019	June 30, 2020	June 30, 2019

	$	$	$	$
Revenues	709,468	16,571	970,371	40,594
Inventory Production Costs expensed to Cost of Sales	(133,481)	–	(234,288)	–
Fair value changes in biological assets included in inventory sold	(540,884)	–	(569,552)	–
Unrealized gain on changes in fair value of biological assets	(88,849)	–	1,827,271	–
General and administrative	2,924,462	4,243,276	6,110,405	6,930,482
Share-based compensation	1,277,770	674,929	1,615,962	1,719,568
Depreciation and amortization	330,685	128,822	839,828	185,117
Impairment of goodwill	686,845	–	686,845	–
Total Expenses	(5,219,762)	(5,047,027)	(9,253,040)	(8,835,167)
Other income (loss)	(2,372,674)	522,257	(2,496,480)	400,898
Net loss before taxes	(7,646,182)	(4,508,199)	(9,755,718)	(8,393,675)
Future income tax recovery	–	–	–	–
Net loss after taxes	(7,646,182)	(4,508,199)	(9,755,718)	(8,393,675)
Weighted average number of Common Shares outstanding – basic and diluted	24,889,167	18,139,300	24,345,387	16,825,405
Loss per share – basic and diluted	(0.36)	(0.25)	(0.48)	(0.49)

Summary of Balance Sheet ($CDN)

	As at June 30, 2020	As at December 31, 2019

Assets	$	$
Cash	81,697	441,757
Amounts receivable	1,428,490	1,202,924
Prepaid assets	930,962	704,632
Biological assets	31,285	117,367
Inventory	3,926,691	1,484,371
Right to use asset	441,581	539,710
Property and equipment	20,990,033	22,622,322
Intangible assets	10,686,561	11,063,900
Derivative asset	1,500,574	3,780,000
Investments	72	72
Goodwill	2,520,382	3,207,227
Total Assets	42,538,328	45,164,282
Liabilities and Equity
Amounts payable	6,335,553	5,177,634
Due to related party	2,249,862	3,319,116
Convertible debentures	742,810	715,626
Derivative liability	825	23,434
Lease liability	464,691	555,339
Term loan	–	–
Deferred revenue	3,228,592	3,323,518
Deferred tax liability	2,173,834	2,173,834
Total Liabilities	15,196,167	15,288,501
Shareholder’s equity	27,342,161	29,875,781
Total Liabilities and Shareholder’s Equity	42,538,328	45,164,282

About Avicanna

Avicanna is a diversified and vertically integrated Canadian biopharmaceutical company focused on the research, development and commercialization of plant-derived cannabinoid-based products for the global consumer, medical, and pharmaceutical market segments.

Avicanna is an established leader in cannabinoid research and development, which it primarily conducts at its R&D headquarters in the Johnson & Johnson Innovation Centre, JLABS @ Toronto, Canada and in collaboration with leading Canadian academic and medical institutions. In addition to its developing pharmaceutical pipeline, Avicanna’s team of experts have developed and commercialized several industry leading product lines, including:

Pura H&W: an advanced and clinically tested line of CBD consumer derma-cosmetic products; and,
RHO Phyto: an advanced line of medical cannabis products containing varying ratios of CBD and THC currently available nation-wide across Canada in partnership with Medical Cannabis by Shoppers™, a subsidiary of Shoppers Drug Mart. RHO Phyto is the first strictly medical formulary of advanced “Cannabis 2.0” products, containing oils, sprays, capsules, creams, and gels, all developed with scientific rigour, manufactured under GMP standards and supported by pre-clinical data.

With ongoing clinical trials on its derma-cosmetic (Pura H&W), medical cannabis (RHO Phyto) and a pipeline of pharmaceutical products, Avicanna’s dedication to researching the important role that cannabinoids play in an increasingly wider scope of products has been at the core of the Company’s vision since its inception. Furthermore, Avicanna’s commitment to education is demonstrated through its annual medical symposium, the Avicanna Academy educational platform, and the My Cannabis Clinic patient program through its subsidiary company.

Avicanna manages its own supply chain including cultivation and extraction through its two majority-owned subsidiaries, Sativa Nativa S.A.S. and Santa Marta Golden Hemp S.A.S., both located in Santa Marta, Colombia. Through these sustainable, economical, and industrial scale subsidiaries, Avicanna cultivates, processes, and commercializes a range of cannabis and hemp cultivars dominant in CBD, CBG, THC, and other cannabinoids for use as active pharmaceutical ingredients. Avicanna’s Avesta Genetica program specializes in the development and optimization of rare cultivars for commercial production along with feminized seeds for global export. In June 2020, Avicanna made history with a shipment of hemp seeds to the United States of America by completing the first ever export of hemp seeds from Colombia.

Stay Connected

For more information about Avicanna, visit www.avicanna.com, call 1-647-243-5283, or contact Setu Purohit, President by email at [email protected].

Cautionary Note Regarding Forward-Looking Information and Statements

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only Avicanna’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of Avicanna’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. The forward-looking information and forward-looking statements contained herein may include, but is not limited to, the ability of the combined expertise of the Company and CARG to fast-track the development of advanced pharmaceutical formulations of cannabinoids and their route to market, the ability of the Company to certify the safety and stability of the Pura H&W formulations not yet registered with the CPNP, the ability of the Company to sell, export and use CBG seeds for local production in Colombia, the ability of the Company to sell the RHO Phyto products in Canada and internationally, the ability of the Company to manufacture pharmaceutical grade products for clinical trials in Canada, and that the RHO Phyto sublingual spray and topical products will be available through Medical Cannabis by Shoppers in Q3 2020 and that capsules will be available for sale through Medical Cannabis by Shoppers in Q4 2020.

By identifying such information and statements in this manner, Avicanna is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Avicanna to be materially different from those expressed or implied by such information and statements. In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, Avicanna has made certain assumptions.

Among others, the key factors that could cause actual results to differ materially from those projected in the forward-looking information and statements are the following: decreases in the prevailing prices for cannabis and cannabis products in the markets in which the Company operates; adverse changes in applicable laws; adverse changes in the application or enforcement of current laws, including those related to taxation; increasing costs of compliance with extensive government regulation; changes in general economic, business and political conditions, including changes in the financial markets and in particular in the ability of the Company to raise debt and equity capital in the amounts and at the costs that it expects; risks related to licensing, including the ability to obtain the requisite licenses or renew existing licenses for the Company’s proposed operations; dependence upon third party service providers, skilled labor and other key inputs; risks inherent in the agricultural and retail business; intellectual property risks; risks related to litigation; dependence upon senior management; and the other risks disclosed in the Company’s annual information form dated April 15, 2020 filed with the Canadian securities regulators and available under the Company’s profile on SEDAR at www.sedar.com. Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.

The statements in this press release are made as of the date of this release. The Company disclaims any intent or obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

SOURCE Avicanna Inc.

Tags: cannabinoids, CSE, Marijuana, Medical Cannabis by Shoppers, Rho Phyto
Posted in All Recent Posts, Avicanna Inc., Featured | Comments Off on Avicanna $AVCN.ca Reports Second Quarter 2020 Financial Results and Provides Corporate Update $WEED.ca $CL.ca $HEXO.ca $RWB.ca

NCAA Division 1 Big East Conference Invites Loop Insights $MTRX.ca to Present Contact Tracing Solutions to Support Safe Resumption of Schools, Stadiums and Facilities $QUIS.ca $MCLD.ca $NXO.ca

Posted by AGORACOM-JC at 7:27 AM on Monday, August 17th, 2020

Announced it has been invited to present its contact tracing solutions to the Athletic Directors of the 11 NCAA Division 1 Schools of the Big East Conference (“Big East”), for the purposes of supporting resumption plans that provide a safe environment for students, faculty, athletes, fans and staff
On August 12th, Big East announced the postponement of its fall sports season out of concern for the welfare of student-athletes during the coronavirus pandemic
Moreover, Big East has yet to determine whether winter and spring sports will take place as scheduled and is in search of safety processes and protocols that will provide for the safe resumption of athletic events

VANCOUVER, BC, Aug. 17, 2020 – Loop Insights Inc. (TSXV: MTRX) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive automated marketing, contact tracing, and contactless solutions to the brick and mortar space, is pleased to announce it has been invited to present its contact tracing solutions to the Athletic Directors of the 11 NCAA Division 1 Schools of the Big East Conference (“Big East”), for the purposes of supporting resumption plans that provide a safe environment for students, faculty, athletes, fans and staff.

BIG EAST HAS ESTABLISHED ITSELF AS ONE OF NATION’S EXCEPTIONAL CONFERENCES

The Big East Conference’s member schools include Villanova University, Georgetown University and St. John’s University and represent more than 150,000 students. Big East institutions are located in the nation’s largest media markets, including New York, Chicago, Philadelphia and Washington, D.C.

Since the relaunch of the Big East in 2013, it has sponsored championship competition in ten men’s and twelve women’s NCAA sanctioned sports, producing 12 national champions.

POSTPONEMENT OF BIG EAST FALL SPORTS SEASON UNTIL SAFE PROCESSES AND PROTOCOLS CAN BE ESTABLISHED

On August 12th, Big East announced the postponement of its fall sports season out of concern for the welfare of student-athletes during the coronavirus pandemic. Moreover, Big East has yet to determine whether winter and spring sports will take place as scheduled and is in search of safety processes and protocols that will provide for the safe resumption of athletic events.

Loop Insights CEO Rob Anson stated”It is both an extraordinary honour and a testament to the reputation of our contact tracing technology to be invited to present our solutions to the head Athletic Directors of The Big East Conference. Though our presentation is being made to the Athletic Directors for the purposes of supporting the resumption of athletic events, our solutions will apply to the entirety of the campus, student body, faculty and facilities to expedite physical attendance and related economic activities.”

LOOP CONTACT TRACING SOLUTION PROVIDES NCAA CONFERENCES WITH AN OPPORTUNITY TO RESTART CAMPUS ACTIVITIES AND ECONOMIC RECOVERY

In 2013, Big East forged a landmark, long-term broadcast partnership with FOX Sports in a 12-year, $500 million television contract. FOX’s comprehensive coverage of BIG EAST men’s basketball includes the broadcast of all regular-season games on FOX, FS1, or FS2, as well as the BIG EAST Tournament at Madison Square Garden, college basketball’s longest-running postseason conference tournament.

The postponement of the falls sports season represents a significant loss of important incomes to all members of Big East, who are in need of solutions that not only support a safe environment for fans, staff and athletes, but also optimize their revenue streams that warrant the restart of operations. Loop effectively solves both of these problems with their leading contact tracing solutions providing the comfort necessary to put on events. With fans streaming into these events, Loop’s contactless, artificial intelligence marketing solutions will provide personalized promotions and targeted engagement, leading to higher conversions and transaction revenue at all of our events.

This Press Release Is Available On The Loop Insights Verified Forum On AGORACOM For Shareholder Discussion and Q&A https://agoracom.com/ir/LoopInsights/forums/discussion

About Loop Insights

Loop Insights Inc. is a Vancouver-based Internet of Things (“IoT”) technology company that delivers transformative artificial intelligence (“AI”) automated marketing, contact tracing, and contactless solutions to the brick and mortar space. Its unique IoT device, Fobi, enables data connectivity across online and on-premise platforms to provide real-time, detailed insights and automated, personalized engagement. Its ability to integrate seamlessly into existing infrastructure, and customize campaigns according to each vertical, creates a highly scalable solution for its prospective global clients that span industries. Loop Insights operates in the telecom, casino gaming, sports and entertainment, hospitality, and retail industries, in Canada, the US, the UK, Latin America, Australia, Japan, and Indonesia.

Forward-Looking Statements/Information:

This news release contains certain statements which constitute forward-looking statements or information. Such forward-looking statements are subject to numerous risks and uncertainties, some of which are beyond Loop’s control, including the impact of general economic conditions, industry conditions, and competition from other industry participants, stock market volatility and the ability to access sufficient capital from internal and external sources. Although Loop believes that the expectations in its forward-looking statements are reasonable, they are based on factors and assumptions concerning future events which may prove to be inaccurate. Those factors and assumptions are based upon currently available information. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors that could influence actual results or events and cause actual results or events to differ materially from those stated, anticipated or implied in the forward-looking statements. As such, readers are cautioned not to place undue reliance on the forward-looking statements, as no assurance can be provided as to future results, levels of activity or achievements. The forward-looking statements contained in this news release are made as of the date of this news release and, except as required by applicable law, Loop does not undertake any obligation to publicly update or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise. The forward-looking statements contained in this document are expressly qualified by this cautionary statement. Trading in the securities of Loop should be considered highly speculative. There can be no assurance that Loop will be able to achieve all or any of its proposed objectives.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE LOOP Insights Inc.

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/August2020/17/c4709.html

Loop Insights Inc., Rob Anson, CEO, T: +1 877-754-5336 Ext. 4, E: [email protected]; LOOP Website: www.loopinsights.ai, Facebook: @LoopInsights, Twitter: @LoopInsights, LinkedIn: @LoopInsightsCopyright CNW Group 2020

Tags: AI, covid19, Covid19 tracing, CSE, internet of things, IOT, tsx, tsx-v
Posted in All Recent Posts, Featured, Loop Insights Inc. | Comments Off on NCAA Division 1 Big East Conference Invites Loop Insights $MTRX.ca to Present Contact Tracing Solutions to Support Safe Resumption of Schools, Stadiums and Facilities $QUIS.ca $MCLD.ca $NXO.ca

VIDEO: Red Light Holland $TRIP.ca #Psychedelics Will Be Hitting The Shelves Soon, Followed By Production of 100,000 Grams Of Magic Truffles

Posted by AGORACOM-JC at 4:02 PM on Thursday, August 13th, 2020

The dawn of the psychedelics industry could not have come at a more needed time for humanity, as global events have served to exacerbate mental health issues related to anxiety and depression. Investors will need help identifying best of breed psychedelics companies and a review of the Red Light Holland story is all you need to know about where the Company is going.

Red Light Holland (TRIP:CSE) is a psychedelics company focused on the development of premium “magic” truffles in the Netherlands. More than just lip service the Company already has these two very strong pillars in place:

TEAM – In order to help guide the company’s development and operations in the psychedelics space, TRIP has signed former Canopy Growth CEO Bruce Linton as chair of its advisory board and Former Canadian Health Minister, Tony Clement, as Senior Advisor. Company President Hans Derix is a native of the Netherlands and an expert in the space with over a decade of accomplished experience.

BUSINESS – The Company’s recreational brand of magic truffles are expected to be sold in the Netherlands through existing Smart Shops by mid-September, as well as, its e-commerce platform through microdose packs. To this end, TRIP has already commenced growing its first crop of magic truffles months ahead of schedule. The initial batch of approximately 100,000 grams of magic truffles available in late October, 2020.

As if that wasn’t enough, TRIP has also produced a virtual reality experience for prospective customers who want to experience the effects of their products before actually trying it. The AGORACOM thesis of small cap wealth this decade is the convergence of emerging technologies – but even we didn’t foresee the explosive intersection of virtual reality and psychedelics!

If you believe in the future of Psychedelics and Psilocybin in particular, then this interview with Todd Shapiro, CEO of Red Light Holland will be a TRIP.

Watch this interview or listen by Podcast on Apple, Google, Spotify or your favourite podcaster.

Tags: #Depression, #Medicine, #psychedelic, #Research, CSE, Magic Truffles, stocks, tsx, tsx-v
Posted in AGORACOM Via Satellite, All Recent Posts, Featured, Red Light Holland | Comments Off on VIDEO: Red Light Holland $TRIP.ca #Psychedelics Will Be Hitting The Shelves Soon, Followed By Production of 100,000 Grams Of Magic Truffles

Datametrex $DM.ca Secures $2.3M Contract

Posted by AGORACOM-JC at 10:07 AM on Thursday, August 13th, 2020

Entered into an additional sales agreement for approximately $2.3M with Lotte Home Shopping Co. Ltd., bringing the total gross sales to $3.3M this year so far
LOTTE Home Shopping operates large retail stores and department stores in various countries like Japan, South Korea, China, and Vietnam
Datametrex is continuously working with the various divisions of LOTTE as a preferred vendor
LOTTE Group is the fifth-largest conglomerate in Korea with annual revenues of approximately USD 60 billion, consisting of over 90 business divisions.

TORONTO, Aug. 13, 2020 — Datametrex AI Limited (the “Company” or “Datametrex“) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that it has entered into an additional sales agreement for approximately $2.3M with Lotte Home Shopping Co. Ltd. (“LOTTE”), bringing the total gross sales to $3.3M this year so far.

LOTTE Home Shopping operates large retail stores and department stores in various countries like Japan, South Korea, China, and Vietnam.

Datametrex is continuously working with the various divisions of LOTTE as a preferred vendor. Datametrex has demonstrated to be a quality, reliable, and trustworthy partner, with an opportunity to grow within the 934 companies in the LOTTE family.

“At Datametrex, we continue our efforts to facilitate ground-breaking technologies to companies across the globe. We pride ourselves in providing tools that our clients can use to visualize their customer and stakeholder data in order to make predictive analyses, mitigate risk, and improve their bottom line,” stated Marshall Gunter, CEO of Datametrex.

Datametrex plans to deliver the contract in August with full payment in September 2020.

Datametrex is also pleased to share that the Company has won a tender from LOTTE Property and Development Co. Ltd. for approximately $100K.

About LOTTE Group

LOTTE Group is the fifth-largest conglomerate in Korea with annual revenues of approximately USD 60 billion, consisting of over 90 business divisions. LOTTE is engaged in diverse industries that include hotels, resorts, fast food, beverages, retail, financial services, heavy chemicals, electronics, IT, construction, publishing, confectionary products, and entertainment. Additional information on LOTTE is available at www.lotte.co.kr

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy. Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Tags: covid19, CSE, datametrex, investments, Lotte, Lotte Home Shopping, PCL, small cap, stocks, tsx, tsx-v
Posted in Datametrex AI Limited, Featured | Comments Off on Datametrex $DM.ca Secures $2.3M Contract

PyroGenesis $PYR.ca Provides Updated EPS Guidance for Third Quarter and Full Year 2020 $RTN $NOC $UTX $DDD.ca $SSYS $PRLB

Posted by AGORACOM-JC at 9:16 AM on Thursday, August 13th, 2020

Updated Earnings Guidance for Q3 2020 and full year 2020:

Management continues to expect significant revenue growth
Q3 2020 updated EPS> $0.07
Full year 2020 updated EPS > $0.11.

MONTREAL, Aug. 13, 2020 — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX-V: PYR) (OTCQB: PYRNF) (FRA: 8PY), a high-tech company, (the “Company”, the “Corporation” or “PyroGenesis”) that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch systems, is pleased to provide today, further to its Q2 2020 financial press release dated July 29th, 2020, updated earnings per share (“EPS”) guidance for Q3 2020, and the full year 2020.

PyroGenesis now expects EPS for Q3 2020 to be in excess of $0.07. On July 29th, 2020, the Company had given prior guidance of $0.06 for the same period. Furthermore, the Company now expects an EPS for the full year 2020 to be conservatively in excess of $0.11.

“We understand the market’s interest in our providing guidance, so we are progressing cautiously and conservatively as we are committed to meet or exceed market expectations,” said P. Peter Pascali, CEO and President of PyroGenesis. “Our confidence, and increased visibility, in our Q3 2020 results has resulted in this update, and we will continue to provide such updates as needed. The Company continues to exceed internal expectations in the execution of all its projects and business lines with little to no impact from the summer holiday period nor the ongoing pandemic.”

Updated Earnings Guidance for Q3 2020 and full year 2020:

Management continues to expect significant revenue growth
Q3 2020 updated EPS> $0.07
Full year 2020 updated EPS > $0.11.

About PyroGenesis Canada Inc.
PyroGenesis Canada Inc., a high-tech company, is the world leader in the design, development, manufacture and commercialization of advanced plasma processes and products. We provide engineering and manufacturing expertise, cutting-edge contract research, as well as turnkey process equipment packages to the defense, metallurgical, mining, advanced materials (including 3D printing), oil & gas, and environmental industries. With a team of experienced engineers, scientists and technicians working out of our Montreal office and our 3,800 m2 manufacturing facility, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. Our core competencies allow PyroGenesis to lead the way in providing innovative plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. Our operations are ISO 9001:2015 and AS9100D certified, and have been since 1997. PyroGenesis is a publicly-traded Canadian Corporation on the TSX Venture Exchange (Ticker Symbol: PYR) and on the OTCQB Marketplace. For more information, please visit www.pyrogenesis.com.

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward- looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Corporation’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Corporation with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Corporation’s ongoing filings with the securities regulatory authorities, which filings can be found at www.sedar.com, or at www.otcmarkets.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Corporation undertakes no obligation to publicly update or revise any forward- looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.

Neither the TSX Venture Exchange, its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) nor the OTCQB accepts responsibility for the adequacy or accuracy of this press release.

SOURCE PyroGenesis Canada Inc.

For further information please contact:
Rodayna Kafal, Vice President Investors Relations and Strategic Business Development
Phone: (514) 937-0002, E-mail: [email protected]
RELATED LINK: https://www.pyrogenesis.com/

Tags: drosrite, plasma, powders, PUREVAP, PyroGenesis, small cap investment, tsx
Posted in All Recent Posts, Featured, PyroGenesis Canada Inc. | Comments Off on PyroGenesis $PYR.ca Provides Updated EPS Guidance for Third Quarter and Full Year 2020 $RTN $NOC $UTX $DDD.ca $SSYS $PRLB

Loop $MTRX.ca Signs Contract with bdG Sports LLC. to Deliver Contact Tracing and Automated Marketing Solutions for NBA, NHL, NCAA and PGA Sporting Events $QUIS.ca $MCLD.ca $NXO.ca

Posted by AGORACOM-JC at 7:09 AM on Thursday, August 13th, 2020

Announced the signing of a channel reseller partnership with Kentucky-based bdG Sports LLC (“bdG”) a leading representation, event management and public relations firm operating within the global sports marketing industry.
bdG Sports is one of the largest providers of college basketball content in the United States, managing multiple NCAA Division I tournaments across North America, including destination tournaments in Southwest Florida, Las Vegas, Canada, and The Bahamas
The firm manages two professional golf tournaments on the Korn Ferry Tour in the Caribbean, and has an extensive background with both the LPGA and PGA TOUR
The firm also boasts relationships with such brands as Nike, ESPN, Gatorade, and MGM Resorts International, among others.

VANCOUVER, BC, Aug. 13, 2020 – Loop Insights Inc. (MTRX:TSXV) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive automated marketing, contact tracing, and contactless solutions to the brick and mortar space, announces the signing of a channel reseller partnership with Kentucky-based bdG Sports LLC (“bdG”) a leading representation, event management and public relations firm operating within the global sports marketing industry.

LOOP CONTACT TRACING SOLUTION PROVIDES BDG SPORTING EVENTS WITH AN OPPORTUNITY TO COMMENCE AND PROVIDE ECONOMIC RECOVERY FOR CLIENTS

bdG Sports is one of the largest providers of college basketball content in the United States, managing multiple NCAA Division I tournaments across North America, including destination tournaments in Southwest Florida, Las Vegas, Canada, and The Bahamas. The firm manages two professional golf tournaments on the Korn Ferry Tour in the Caribbean, and has an extensive background with both the LPGA and PGA TOUR. The firm boasts relationships with such brands as Nike, ESPN, Gatorade, and MGM Resorts International, among others. As a result of COVID-19, these staple events and many other bdG events have been disrupted, with no plans for commencement without a solution for the safety of fans, athletes, and staff.

President and CEO of bdG Sports, Brooks Downing, said: “Many within our extensive network of business are desperately searching for innovative solutions that will allow them the opportunity to support a safe environment for fans, staff and athletes, but also optimize their revenue streams that warrant the restart of operations. Loop effectively solves both of these problems with its leading contact-tracing solution which will provide the confidence needed as teams make decisions to restart their schedules. And while this tool will allow fans to return to events, Loop’s contactless, artificial intelligence marketing solutions will provide personalized promotions and targeted engagement, leading to higher conversions and transaction revenue at all events. This level of personalized omni-channel marketing is incredibly valuable for our clients’ resumption plans.”

BDG PROVIDES DIRECT ACCESS TO ITS LIVE GLOBAL SPORTING EVENTS AND TO ITS LARGE NETWORK OF CLIENTS WITHIN NBA, NHL, NCAA AND PGA

In addition to implementing Loop’s contact tracing product into its current and future events, bdG Sports also plays host to major global sports events and will be implementing Loop’s solutions to reinvent the live fan engagement experience, consisting of real-time personalized fan engagement.

Additionally, bdG will represent Loop as a reseller to its current and future clients and enables direct access to the bdG Sports client base, which the Company anticipates will accelerate its growth opportunities in the sports industry.

Loop CEO, Rob Anson, stated: “This is a major opportunity for Loop as live event operators are looking for two things that we can immediately solve. First, they are desperately looking to safely re-open facilities in efforts to save their respective seasons, and secondly, they are looking for new line revenue opportunities to offset the losses from reduced fan capacity in stadium. This partnership with globally renowned bdG Sports is major third-party validation of our abilities to deliver these solutions. We look forward to leading the way with them toward the safe and profitable resumption of major sporting events.”

Watch Loop CEO, Rob Anson and bdG Sports CEO, Brooks Downing discuss their new partnership https://youtu.be/cL5wfYNO-Qs

This Press Release Is Available On The Loop Insights Verified Forum On AGORACOM For Shareholder Discussion and Q&A https://agoracom.com/ir/LoopInsights/forums/discussion

About bdG Sports:
bdG Sports is a representation, event management, and public relations firm operating on an international platform within the sports marketing industry. bdG manages multiple college basketball and college hockey events in the United States each season with events in Southwest Florida, Las Vegas and The Bahamas. bdG’s golf division manages the season-opening tournaments of the Korn Ferry Tour each January in The Bahamas, hosts premium Pro-Ams throughout the year and launched the Unbridled Tour mini-tour series in 2020. For more information, visit www.bdglobalsports.com or follow on @bdGlobalSports on Twitter, Facebook or Instagram.

About Loop Insights:
Loop Insights Inc. is a Vancouver-based Internet of Things (“IoT”) technology company that delivers transformative artificial intelligence (“AI”) automated marketing, contact tracing, and contactless solutions to the brick and mortar space. Its unique IoT device, Fobi, enables data connectivity across online and on-premise platforms to provide real-time, detailed insights and automated, personalized engagement. Its ability to integrate seamlessly into existing infrastructure, and customize campaigns according to each vertical, creates a highly scalable solution for its prospective global clients that span industries. Loop Insights operates in the telecom, casino gaming, sports and entertainment, hospitality, and retail industries, in Canada, the US, the UK, Latin America, Australia, Japan, and Indonesia.

Forward-Looking Statements/Information:

SOURCE LOOP Insights Inc.

Tags: AI, covid19, Covid19 tracing, CSE, internet of things, IOT
Posted in All Recent Posts, Featured, Loop Insights Inc. | Comments Off on Loop $MTRX.ca Signs Contract with bdG Sports LLC. to Deliver Contact Tracing and Automated Marketing Solutions for NBA, NHL, NCAA and PGA Sporting Events $QUIS.ca $MCLD.ca $NXO.ca

CLIENT FEATURE: Loop Insights $MTRX.ca Leveling the playing field between online retail giants and brick & mortar businesses $QUIS.ca $MCLD.ca $NXO.ca

Posted by AGORACOM-JC at 5:25 PM on Wednesday, August 12th, 2020

(TSXV: MTRX)

WHY LOOP INSIGHTS?

What if you could receive the same personalization and experience you get from online shopping, but in brick and mortar stores? Loop Insights is doing just that.

Brick and mortar retail isn’t going anywhere, but it does need to adapt to offer better in-store customer experiences. Loop Insights solves a significant problem for traditional retailers – big and small – who are losing customers to e-commerce retail.

All e-commerce sites have easy access to company-wide connectivity, real-time insights, and personalized marketing. What Loop is doing is creating those same tools for physical retail, whether it is a restaurant, hotel, casino, store, or stadium.

Loop’s proprietary internet of things (IoT) device, Fobi, makes it all happen. It can be installed in minutes using an API or hardware solution, making Loop’s services ultimately scalable no matter what infrastructure is currently set up in the store.

NORTH AMERICA’S BIGGEST MOBILE COMPANIES BELIEVE

SEEING IS BELIEVING

Now that you have an understanding of the magnitude of the problem and the disruptive power of LOOP, you need to see it for yourself. Watch this short but powerful videos demonstrating how LOOP is being applied across different verticals to solve brick and mortar retail problems.

Hub On AGORACOM / Corporate Profile

FULL DISCLOSURE: Loop Insights is an advertising client of AGORA Internet Relations Corp.

Tags: AI, covid19, Covid19 tracing, CSE, internet of things, IOT, tsx
Posted in AGORACOM Client Feature, All Recent Posts, Featured, Loop Insights Inc. | Comments Off on CLIENT FEATURE: Loop Insights $MTRX.ca Leveling the playing field between online retail giants and brick & mortar businesses $QUIS.ca $MCLD.ca $NXO.ca

HPQ Silicon $HPQ.ca Well-Funded to Accelerate Leading Nano Silicon Initiatives for Batteries and Other Renewable Energy Applications for 2020 and Beyond $PYR.ca $DUK $XEL $NEE

Posted by AGORACOM-JC at 10:05 AM on Wednesday, August 12th, 2020

Announced that since the start of June 2020, the Company has raised over $1,452,401 through the exercise of various financial instruments.
During the period ended June 30, 2020, $182,277 was raised, at an average price of $0.122 per share, through the exercise of 1,087,000 warrants, 178,000 broker warrants and 175,000 broker units.
Furthermore, since the start of Q3 another $1,270,124 was raised, at an average price of $0.121 per share, through the exercise of 7,959,588 warrants, 81,430 brokers warrant and 2,400,000 options.
During the same period the 11,881,738 financial instruments were exercise, HPQ traded 156,507,300 shares for a value of $55,789,137 at an average price of $0.356.
While the volume generated represented 60% of HPQ outstanding shares, the shares issued on exercise represented only 7.6% of the trading volume.

MONTREAL, Aug. 12, 2020 — HPQ Silicon Resources Inc. (“HPQ” or the “Company”) TSX-V: HPQ; FWB: UGE; Other OTC : URAGF; is pleased to announced that since the start of June 2020, the Company has raised over $1,452,401 through the exercise of various financial instruments.

During the period ended June 30, 2020, $182,277 was raised, at an average price of $0.122 per share, through the exercise of 1,087,000 warrants, 178,000 broker warrants and 175,000 broker units. Furthermore, since the start of Q3 another $1,270,124 was raised, at an average price of $0.121 per share, through the exercise of 7,959,588 warrants, 81,430 brokers warrant and 2,400,000 options.

During the same period the 11,881,738 financial instruments were exercise, HPQ traded 156,507,300 shares for a value of $55,789,137 at an average price of $0.356. While the volume generated represented 60% of HPQ outstanding shares, the shares issued on exercise represented only 7.6% of the trading volume.

Presently HPQ cash on hand, liquid investment in public companies, and cash reserved for the PUREVAPTM QRR pilot plant project, total $4,725,221. In addition, the $11,482,557 cash value of outstanding in the money warrants and options, (80% of those are owned by PyroGenesis, Investisement Québec (IQ), insiders and strategic investors), provides HPQ access to over $16M. This is enough sources of funds to develop, to commercial scale, the game changing PUREVAP™ family of processes HPQ is developing with Pyrogenesis namely:

The PUREVAP™ “Quartz Reduction Reactors” (QRR), an innovative process (patent pending), which will permit the one step transformation of quartz (SiO2) into high purity silicon (Si) at reduced costs, energy input, and carbon footprint that will propagate its considerable renewable energy potential; and
The PUREVAP™ Nano Silicon Reactor (NSiR), a new proprietary process that use PUREVAPTM QRR silicon (Si) as feedstock, to make spherical silicon nanopowders and nanowires.”

“Since the start of the year, HPQ has made great strides toward its goal of becoming a leader in the field of Nano silicon materials production, and we very grateful for the market support we have received over the last few months and the resultant financings.” said Bernard Tourillon, President & CEO of HPQ Silicon. “Our PUREVAPTM processes open up unique multibillion-dollar business opportunity for HPQ and PyroGenesis, as we strive to deliver the critical and economically viable Silicon nano- materials required by the surging Li-ion battery market and other large renewable energy markets.”

POTENTIAL OF OUR PUREVAPTM NANO SILICON (Si) REACTOR GETTING NOTICED

The PUREVAPTM NSiR process is purposely being developed to address the fact that current manufacturing processes to make Nano Silicon (Si) Powders are not very scalable and simply too expensive to be commercially feasible, requiring up to US$ 30,000/kg1 selling prices to justify production. HPQ and partner Pyrogenesis are working to develop commercially scalable Nano Silicon powder production and have caught the attention of significant industry players. The company continues to evaluate and discuss potential opportunities under Confidentiality Agreements and cannot provide further commentary at this time.

About Silicon

Silicon (Si), also known as silicon metal, is one of today’s strategic materials needed to fulfil the Renewable Energy Revolution (“RER”) presently under way. Silicon does not exist in its pure state; it must be extracted from quartz (SiO2), in what has historically been a capital and energy intensive process.

About HPQ Silicon

HPQ Silicon Resources Inc. (TSX-V: HPQ) is a Canadian producer of Innovative Silicon Solutions, based in Montreal, building a portfolio of unique high value specialty silicon products needed for the coming RER.

Working with PyroGenesis Canada Inc. (TSX-V: PYR), a high-tech company that designs, develops, manufactures and commercializes plasma – based processes, HPQ is developing:

The PUREVAPTM “Quartz Reduction Reactors” (QRR), an innovative process (patent pending), which will permit the one step transformation of quartz (SiO2) into high purity silicon (Si) at reduced costs, energy input, and carbon footprint that will propagate its considerable renewable energy potential;
- HPQ believes it will become the lowest cost (Capex and Opex) producer of silicon (Si) and high purity silicon metal (3N – 4N Si);
The PUREVAPTM Nano Silicon Reactor (NSiR), a new proprietary process that can use different purities of silicon (Si) as feedstock, to make spherical silicon nanopowders and nanowires;
- HPQ believes it can also become the lowest cost manufacturer of spherical Si nanopowders and silicon-based composites needed by manufacturers of next-generation lithium-ion batteries;
- During the coming months, spherical Si nanopowders and nanowires silicon-based composite samples requested by industry participants and research institutions’ will be produced using PUREVAPTM SiNR.

HPQ is also working with industry leader Apollon Solar of France to:

Use their patented process and develop a capability to produce commercially porous silicon (Si) wafers and porous silicon (Si) powders;
- The collaboration will allow HPQ to become the lowest cost producer of porous silicon wafers for all-solid -state batteries and porous silicon powders for Li-ion batteries.
- The plan is to deliver porous Si wafer to a battery manufacturer (under NDA) for testing in 2020.

This News Release is available on the company’s CEO Verified Discussion Forum, a moderated social media platform that enables civilized discussion and Q&A between Management and Shareholders.

Disclaimers:

The Corporation’s interest in developing the PUREVAP™ QRR and any projected capital or operating cost savings associated with its development should not be construed as being related to the establishing the economic viability or technical feasibility of any of the Company’s Quartz Projects.

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward-looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Company’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Company with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Company’s on-going filings with the security’s regulatory authorities, which filings can be found at www.sedar.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.

For further information contact

Bernard J. Tourillon, Chairman, President and CEO Tel (514) 907-1011
Patrick Levasseur, Vice-President and COO Tel: (514) 262-9239
http://www.hpqsilicon.com Email: [email protected]

Posted in Featured, HPQ-Silicon Resources Inc. | Comments Off on HPQ Silicon $HPQ.ca Well-Funded to Accelerate Leading Nano Silicon Initiatives for Batteries and Other Renewable Energy Applications for 2020 and Beyond $PYR.ca $DUK $XEL $NEE

Archive for the ‘Featured’ Category

Categories